Risk and Volatility
SBC Medical Group has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, SBC Medical Group’s peers have a beta of 1.62, indicating that their average share price is 62% more volatile than the S&P 500.
Earnings and Valuation
This table compares SBC Medical Group and its peers top-line revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
SBC Medical Group | $205.42 million | $46.61 million | 12.59 |
SBC Medical Group Competitors | $13.01 billion | $237.07 million | 36.48 |
SBC Medical Group’s peers have higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Institutional & Insider Ownership
Profitability
This table compares SBC Medical Group and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
SBC Medical Group | 17.71% | 20.76% | 15.56% |
SBC Medical Group Competitors | -772.27% | -49.31% | -10.57% |
Summary
SBC Medical Group beats its peers on 5 of the 9 factors compared.
SBC Medical Group Company Profile
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.